Blog

Home  /  EUnetHTA Joint Action 3 (2016-2021)   /  OTCA21 ‘Hypoglossal Nerve Stimulation (HGNS) for treatment of obstructive sleep apnea’ Final Assessment now available

OTCA21 ‘Hypoglossal Nerve Stimulation (HGNS) for treatment of obstructive sleep apnea’ Final Assessment now available

EUnetHTA is pleased to announce that the OTCA21 Final Assessment is now available for access.

The assessed technology is Hypoglossal Nerve Stimulation (HGNS) for treatment of obstructive sleep apnea. The aim of this assessment was to evaluate effectiveness and safety of HGNS compared with no treatment in those adult patients with moderate-to-severe obstructive sleep apnea (OSA) who present inadequate adherence to positive airway pressure systems or to other non-invasive procedures.

OTCA21 – Final Assessment Report

OTCA21 – External Review by Experts and Fact-Check by Manufacturers

OTCA21 – Final Project Plan

OTCA21 – Plain Language Summary

OTCA21 – Comments from external experts and manufacturers including author replies